Page last updated: 2024-10-23

benzamide and Parkinsonian Disorders

benzamide has been researched along with Parkinsonian Disorders in 1 studies

benzamide : An aromatic amide that consists of benzene bearing a single carboxamido substituent. The parent of the class of benzamides.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
"Posttreatment with benzamide also attenuated MPTP neurotoxicity in mice."1.36Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. ( Araki, T; Kato, H; Kuroiwa, H; Tsukada, T; Uchida, H; Yokoyama, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yokoyama, H1
Kuroiwa, H1
Tsukada, T1
Uchida, H1
Kato, H1
Araki, T1

Other Studies

1 other study available for benzamide and Parkinsonian Disorders

ArticleYear
Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.
    Journal of neuroscience research, 2010, May-15, Volume: 88, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzamides; Brain; Disease Models, Animal; En

2010